Breaking News Instant updates and real-time market news.

IONS

Ionis Pharmaceuticals

$52.02 /

-0.52 (-0.99%)

12:27
11/18/20
11/18
12:27
11/18/20
12:27

Ionis Pharmaceuticals participates in a conference call with JPMorgan

SMid Cap Biotech Analyst Fye holds a conference call with CEO Monia and CFO Hougen on November 18 at 2 pm hosted by JPMorgan.

IONS Ionis Pharmaceuticals
$52.02 /

-0.52 (-0.99%)

09/23/20 BMO Capital
Ionis Pharmaceuticals' Spinraza benefits from Novartis' AVXS-101 delay, says BMO
09/23/20 SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
09/22/20 Cantor Fitzgerald
Ionis Pharmaceuticals price target raised to $59 from $56 at Cantor Fitzgerald
09/14/20 JPMorgan
Ionis Pharmaceuticals resumed with a Neutral at JPMorgan

TODAY'S FREE FLY STORIES

General news
, with core yields now about 1 bp to 2.4 bps richer as many stock markets » 07:45
01/25/21
01/25
07:45
01/25/21
07:45

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Cowen Group appoints Kelly Wiegel to management committee » 07:44
01/25/21
01/25
07:44
01/25/21
07:44
COWN

Cowen Group

$27.22 /

-0.49 (-1.77%)

Cowen announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COWN Cowen Group
$27.22 /

-0.49 (-1.77%)

COWN Cowen Group
$27.22 /

-0.49 (-1.77%)

12/02/20 JMP Securities
Cowen Group price target raised to $32 from $25 at JMP Securities
11/23/20 Piper Sandler
Cowen Group price target raised to $35 from $25 at Piper Sandler
07/22/20 Wolfe Research
Cowen Group initiated with an Outperform at Wolfe Research
COWN Cowen Group
$27.22 /

-0.49 (-1.77%)

Hot Stocks
OFG Bancorp: Q4 results reflect pre-tax merger, restructuring charges of $10.1M  07:44
01/25/21
01/25
07:44
01/25/21
07:44
OFG

OFG Bancorp

$19.19 /

+ (+0.00%)

 
ShowHide Related Items >><<
OFG OFG Bancorp
$19.19 /

+ (+0.00%)

Hot Stocks
Kimberly-Clark CEO sees 'higher commodity costs' in 2021 » 07:44
01/25/21
01/25
07:44
01/25/21
07:44
KMB

Kimberly-Clark

$132.24 /

+1.14 (+0.87%)

Chairman and CEO Mike Hsu…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KMB Kimberly-Clark
$132.24 /

+1.14 (+0.87%)

KMB Kimberly-Clark
$132.24 /

+1.14 (+0.87%)

01/21/21 Deutsche Bank
Kimberly-Clark price target lowered to $144 from $150 at Deutsche Bank
01/19/21 Bernstein
Kimberly-Clark initiated with a Market Perform at Bernstein
12/07/20 Wells Fargo
Kimberly-Clark initiated with an Underweight at Wells Fargo
10/16/20
Fly Intel: Top five analyst initiations
KMB Kimberly-Clark
$132.24 /

+1.14 (+0.87%)

KMB Kimberly-Clark
$132.24 /

+1.14 (+0.87%)

Hot Stocks
Revival Gold extends Haidee Zone with 2020 drilling results » 07:43
01/25/21
01/25
07:43
01/25/21
07:43
RVLGF

Revival Gold

$0.00 /

+ (+0.00%)

Revival Gold is pleased…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RVLGF Revival Gold
$0.00 /

+ (+0.00%)

RVLGF Revival Gold
$0.00 /

+ (+0.00%)

08/28/20 PI Financial
Revival Gold price target lowered to C$1.35 from C$1.40 at PI Financial
Hot Stocks
Ucommune International announces additional investment in Xiyu Information » 07:43
01/25/21
01/25
07:43
01/25/21
07:43
UK

Ucommune International

$4.87 /

-0.115 (-2.31%)

Ucommune International…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Schrodinger price target raised to $117 from $97 at BMO Capital » 07:42
01/25/21
01/25
07:42
01/25/21
07:42
SDGR

Schrodinger

$95.64 /

+0.87 (+0.92%)

BMO Capital analyst Do…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SDGR Schrodinger
$95.64 /

+0.87 (+0.92%)

SDGR Schrodinger
$95.64 /

+0.87 (+0.92%)

11/23/20 BofA
BofA upgrades Schrodinger to Buy after 'major' collaboration announcement
11/23/20 BofA
Schrodinger upgraded to Buy from Neutral at BofA
10/12/20 Jefferies
Schrodinger upgraded to Buy from Hold at Jefferies
08/10/20
Schrodinger files to sell 4.5M shares of common stock
SDGR Schrodinger
$95.64 /

+0.87 (+0.92%)

  • 13
    Aug
  • 06
    Feb
SDGR Schrodinger
$95.64 /

+0.87 (+0.92%)

SDGR Schrodinger
$95.64 /

+0.87 (+0.92%)

Hot Stocks
Philips' Stellarex drug-coated balloon meets safety goals in two studies » 07:42
01/25/21
01/25
07:42
01/25/21
07:42
PHG

Philips

$55.60 /

+0.22 (+0.40%)

Royal Philips announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PHG Philips
$55.60 /

+0.22 (+0.40%)

PHG Philips
$55.60 /

+0.22 (+0.40%)

07:03 Today Morgan Stanley
iRhythm price target raised to $288 from $227 at Morgan Stanley
01/20/21 Berenberg
Philips price target raised to EUR 50 from EUR 49 at Berenberg
01/19/21 JPMorgan
Philips price target raised to EUR 44 from EUR 39.40 at JPMorgan
11/12/20 Berenberg
Philips price target raised to EUR 49 from EUR 46 at Berenberg
PHG Philips
$55.60 /

+0.22 (+0.40%)

PHG Philips
$55.60 /

+0.22 (+0.40%)

PHG Philips
$55.60 /

+0.22 (+0.40%)

Earnings
OptimizeRx sees 2020 revenue approx. $43M, consensus $37.99M » 07:41
01/25/21
01/25
07:41
01/25/21
07:41
OPRX

OptimizeRx

$44.66 /

+1.63 (+3.79%)

Up 75% over 2019.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OPRX OptimizeRx
$44.66 /

+1.63 (+3.79%)

OPRX OptimizeRx
$44.66 /

+1.63 (+3.79%)

01/07/21 Lake Street
OptimizeRx price target raised to $40 from $26 at Lake Street
01/07/21 Roth Capital
OptimizeRx price target raised to $70 from $40 at Roth Capital
01/04/21 B. Riley Securities
OptimizeRx price target raised to $50 from $34 at B. Riley Securities
11/11/20 B. Riley Securities
OptimizeRx price target raised to $34 from $30 at B. Riley Securities
OPRX OptimizeRx
$44.66 /

+1.63 (+3.79%)

OPRX OptimizeRx
$44.66 /

+1.63 (+3.79%)

Hot Stocks
Axon to change Nasdaq symbol to 'AXON,' effective January 26 » 07:41
01/25/21
01/25
07:41
01/25/21
07:41
AAXN

Axon

$170.40 /

+7.83 (+4.82%)

, AXON

Axon

$0.00 /

+ (+0.00%)

Axon announced that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AAXN Axon
$170.40 /

+7.83 (+4.82%)

AAXN Axon
$170.40 /

+7.83 (+4.82%)

01/15/21
Fly Intel: Top five analyst upgrades
01/15/21 Morgan Stanley
Axon upgraded to Overweight on new market penetration at Morgan Stanley
01/15/21 Morgan Stanley
Axon upgraded to Overweight from Equal Weight at Morgan Stanley
12/16/20 JMP Securities
Axon cut to Market Perform at JMP Securities, sees stock as fairly valued
AXON Axon
$0.00 /

+ (+0.00%)

AAXN Axon
$170.40 /

+7.83 (+4.82%)

  • 17
    Jun
AAXN Axon
$170.40 /

+7.83 (+4.82%)

AAXN Axon
$170.40 /

+7.83 (+4.82%)

Hot Stocks
The9 signs investment agreement with Jianping Kong, others » 07:41
01/25/21
01/25
07:41
01/25/21
07:41
NCTY

The9

$11.13 /

+2.08 (+22.98%)

, CAN

Canaan

$4.86 /

+0.07 (+1.46%)

The9 (NCTY) signed the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NCTY The9
$11.13 /

+2.08 (+22.98%)

CAN Canaan
$4.86 /

+0.07 (+1.46%)

NCTY The9
$11.13 /

+2.08 (+22.98%)

CAN Canaan
$4.86 /

+0.07 (+1.46%)

CAN Canaan
$4.86 /

+0.07 (+1.46%)

Earnings
OptimizeRx sees Q4 revenue approx. $16M, consensus $11.1M » 07:40
01/25/21
01/25
07:40
01/25/21
07:40
OPRX

OptimizeRx

$44.66 /

+1.63 (+3.79%)

Up 117% versus the fourth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OPRX OptimizeRx
$44.66 /

+1.63 (+3.79%)

OPRX OptimizeRx
$44.66 /

+1.63 (+3.79%)

01/07/21 Lake Street
OptimizeRx price target raised to $40 from $26 at Lake Street
01/07/21 Roth Capital
OptimizeRx price target raised to $70 from $40 at Roth Capital
01/04/21 B. Riley Securities
OptimizeRx price target raised to $50 from $34 at B. Riley Securities
11/11/20 B. Riley Securities
OptimizeRx price target raised to $34 from $30 at B. Riley Securities
OPRX OptimizeRx
$44.66 /

+1.63 (+3.79%)

OPRX OptimizeRx
$44.66 /

+1.63 (+3.79%)

Periodicals
Arrowhead files IND for study of ARO-ANG3 for treatment of mixed dyslipidemia » 07:40
01/25/21
01/25
07:40
01/25/21
07:40
ARWR

Arrowhead

$82.12 /

+2.01 (+2.51%)

Arrowhead Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARWR Arrowhead
$82.12 /

+2.01 (+2.51%)

ARWR Arrowhead
$82.12 /

+2.01 (+2.51%)

12/21/20 Baird
Arrowhead near-term risks move Baird to the sidelines
12/21/20 Baird
Arrowhead downgraded to Neutral from Outperform at Baird
12/15/20 UBS
Arrowhead initiated with a Buy at UBS
11/24/20 RBC Capital
Arrowhead price target raised to $80 from $62 at RBC Capital
ARWR Arrowhead
$82.12 /

+2.01 (+2.51%)

ARWR Arrowhead
$82.12 /

+2.01 (+2.51%)

ARWR Arrowhead
$82.12 /

+2.01 (+2.51%)

ARWR Arrowhead
$82.12 /

+2.01 (+2.51%)

Hot Stocks
Parsons to lead industry team to work with U.S. Air Forces in Europe and Africa » 07:39
01/25/21
01/25
07:39
01/25/21
07:39
PSN

Parsons

$38.55 /

+0.35 (+0.92%)

, LDOS

Leidos

$112.18 /

+2.84 (+2.60%)

, SAIC

SAIC

$101.05 /

+1 (+1.00%)

Parsons (PSN) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PSN Parsons
$38.55 /

+0.35 (+0.92%)

LDOS Leidos
$112.18 /

+2.84 (+2.60%)

SAIC SAIC
$101.05 /

+1 (+1.00%)

PSN Parsons
$38.55 /

+0.35 (+0.92%)

05/05/20 Wells Fargo
Parsons price target raised to $39 from $33 at Wells Fargo
04/15/20 Benchmark
Parsons initiated with a Buy at Benchmark
04/02/20 Wells Fargo
Parsons price target lowered to $33 from $42 at Wells Fargo
03/30/20 William Blair
Parsons initiated with an Outperform at William Blair
LDOS Leidos
$112.18 /

+2.84 (+2.60%)

11/03/20 Credit Suisse
Leidos price target lowered to $120 from $131 at Credit Suisse
09/23/20 Barclays
Barclays upgrades Leidos to Overweight, sees above peer growth in 2021
09/23/20 Barclays
Leidos upgraded to Overweight from Equal Weight at Barclays
09/22/20 JPMorgan
Leidos upgraded to Overweight on bottomed estimates at JPMorgan
SAIC SAIC
$101.05 /

+1 (+1.00%)

09/24/20 William Blair
William Blair uncovers second large, unannounced contract win for SAIC
09/16/20 William Blair
SAIC seems to have won 8th largest contract at $753M, says William Blair
09/08/20 JPMorgan
SAIC removed from Analyst Focus List at JPMorgan
09/03/20 Citi
SAIC price target raised to $105 from $100 at Citi
PSN Parsons
$38.55 /

+0.35 (+0.92%)

LDOS Leidos
$112.18 /

+2.84 (+2.60%)

SAIC SAIC
$101.05 /

+1 (+1.00%)

PSN Parsons
$38.55 /

+0.35 (+0.92%)

SAIC SAIC
$101.05 /

+1 (+1.00%)

Periodicals
Arrowhead files IND for study of ARO-ANG3 for treatment of mixed dyslipidemia » 07:39
01/25/21
01/25
07:39
01/25/21
07:39
ARWR

Arrowhead

$82.12 /

+2.01 (+2.51%)

Arrowhead Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARWR Arrowhead
$82.12 /

+2.01 (+2.51%)

ARWR Arrowhead
$82.12 /

+2.01 (+2.51%)

12/21/20 Baird
Arrowhead near-term risks move Baird to the sidelines
12/21/20 Baird
Arrowhead downgraded to Neutral from Outperform at Baird
12/15/20 UBS
Arrowhead initiated with a Buy at UBS
11/24/20 RBC Capital
Arrowhead price target raised to $80 from $62 at RBC Capital
ARWR Arrowhead
$82.12 /

+2.01 (+2.51%)

ARWR Arrowhead
$82.12 /

+2.01 (+2.51%)

ARWR Arrowhead
$82.12 /

+2.01 (+2.51%)

Hot Stocks
The9 signs MOUs on purchase of Bitcoin mining machines » 07:39
01/25/21
01/25
07:39
01/25/21
07:39
NCTY

The9

$11.13 /

+2.08 (+22.98%)

The9 announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NCTY The9
$11.13 /

+2.08 (+22.98%)

NCTY The9
$11.13 /

+2.08 (+22.98%)

Recommendations
Kansas City Southern price target raised to $246 from $237 at Credit Suisse » 07:39
01/25/21
01/25
07:39
01/25/21
07:39
KSU

Kansas City Southern

/

+

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KSU Kansas City Southern
/

+

KSU Kansas City Southern
/

+

07:28 Today Benchmark
Kansas City Southern transferred at Benchmark with unchanged Hold rating
07:19 Today Morgan Stanley
Kansas City Southern price target raised to $200 from $142 at Morgan Stanley
07:11 Today Barclays
Kansas City Southern price target raised to $235 from $220 at Barclays
01/15/21 Raymond James
Kansas City Southern price target raised to $245 from $210 at Raymond James
KSU Kansas City Southern
/

+

KSU Kansas City Southern
/

+

KSU Kansas City Southern
/

+

KSU Kansas City Southern
/

+

Initiation
KemPharm initiated with a Buy at Roth Capital » 07:39
01/25/21
01/25
07:39
01/25/21
07:39
KMPH

KemPharm

$6.06 /

+0.07 (+1.17%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KMPH KemPharm
$6.06 /

+0.07 (+1.17%)

KMPH KemPharm
$6.06 /

+0.07 (+1.17%)

05/20/20 H.C. Wainwright
KemPharm price target lowered to $1.50 from $2.50 at H.C. Wainwright
KMPH KemPharm
$6.06 /

+0.07 (+1.17%)

Hot Stocks
Arbutus Biopharma sees cash runway into mid-2022 » 07:38
01/25/21
01/25
07:38
01/25/21
07:38
ABUS

Arbutus Biopharma

$4.04 /

+0.08 (+2.02%)

Arbutus had approximately…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABUS Arbutus Biopharma
$4.04 /

+0.08 (+2.02%)

ABUS Arbutus Biopharma
$4.04 /

+0.08 (+2.02%)

12/17/20 H.C. Wainwright
Arbutus Biopharma initiated with a Buy at H.C. Wainwright
09/15/20 Chardan
Arbutus HBV data 'could represent a turning point,' says Chardan
07/27/20 B. Riley FBR
Arbutus Biopharma price target raised to $8 from $6 at B. Riley FBR
07/24/20 Baird
Arbutus Biopharma upside priced in, Baird downgrades to Neutral
ABUS Arbutus Biopharma
$4.04 /

+0.08 (+2.02%)

ABUS Arbutus Biopharma
$4.04 /

+0.08 (+2.02%)

ABUS Arbutus Biopharma
$4.04 /

+0.08 (+2.02%)

Hot Stocks
Everbridge awarded statewide vaccine distribution deployment in West Virginia » 07:37
01/25/21
01/25
07:37
01/25/21
07:37
EVBG

Everbridge

$141.63 /

-3.09 (-2.14%)

Everbridge announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVBG Everbridge
$141.63 /

-3.09 (-2.14%)

EVBG Everbridge
$141.63 /

-3.09 (-2.14%)

01/15/21 Credit Suisse
Everbridge downgraded to Neutral at Credit Suisse as Shah assumes coverage
01/15/21 Credit Suisse
Everbridge downgraded to Neutral from Outperform at Credit Suisse
11/06/20 Canaccord
Everbridge price target raised to $180 from $170 at Canaccord
10/28/20 BofA
Everbridge downgraded to Neutral from Buy at BofA
EVBG Everbridge
$141.63 /

-3.09 (-2.14%)

Hot Stocks
Arbutus Biopharma announces 2021 corporate objectives » 07:37
01/25/21
01/25
07:37
01/25/21
07:37
ABUS

Arbutus Biopharma

$4.04 /

+0.08 (+2.02%)

Summary of 2021 Corporate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABUS Arbutus Biopharma
$4.04 /

+0.08 (+2.02%)

ABUS Arbutus Biopharma
$4.04 /

+0.08 (+2.02%)

12/17/20 H.C. Wainwright
Arbutus Biopharma initiated with a Buy at H.C. Wainwright
09/15/20 Chardan
Arbutus HBV data 'could represent a turning point,' says Chardan
07/27/20 B. Riley FBR
Arbutus Biopharma price target raised to $8 from $6 at B. Riley FBR
07/24/20 Baird
Arbutus Biopharma upside priced in, Baird downgrades to Neutral
ABUS Arbutus Biopharma
$4.04 /

+0.08 (+2.02%)

ABUS Arbutus Biopharma
$4.04 /

+0.08 (+2.02%)

ABUS Arbutus Biopharma
$4.04 /

+0.08 (+2.02%)

Recommendations
Lam Research price target raised to $650 from $450 at Credit Suisse » 07:37
01/25/21
01/25
07:37
01/25/21
07:37
LRCX

Lam Research

$563.92 /

-0.27 (-0.05%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LRCX Lam Research
$563.92 /

-0.27 (-0.05%)

LRCX Lam Research
$563.92 /

-0.27 (-0.05%)

07:02 Today Deutsche Bank
Lam Research price target raised to $575 from $500 at Deutsche Bank
06:38 Today Citi
Citi moves Marvell up to pick in semiconductor equipment
06:30 Today Citi
Lam Research price target raised to $660 from $420 at Citi
01/18/21 Goldman Sachs
Lam Research price target raised to $616 from $557 at Goldman Sachs
LRCX Lam Research
$563.92 /

-0.27 (-0.05%)

LRCX Lam Research
$563.92 /

-0.27 (-0.05%)

LRCX Lam Research
$563.92 /

-0.27 (-0.05%)

LRCX Lam Research
$563.92 /

-0.27 (-0.05%)

Hot Stocks
CVS Health administered first round of COVID-19 vaccine doses » 07:35
01/25/21
01/25
07:35
01/25/21
07:35
CVS

CVS Health

$74.11 /

+0.04 (+0.05%)

CVS Health has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVS CVS Health
$74.11 /

+0.04 (+0.05%)

CVS CVS Health
$74.11 /

+0.04 (+0.05%)

01/22/21 Baird
Tabula Rasa HealthCare may have lost MTM deal at Aetna, says Baird
01/19/21 JPMorgan
Teladoc remains top 2021 healthcare technology pick at JPMorgan
01/08/21
Fly Intel: Top five analyst upgrades
01/08/21 Jefferies
CVS Health upgraded to Buy on COVID-19 vaccination upside at Jefferies
CVS CVS Health
$74.11 /

+0.04 (+0.05%)

CVS CVS Health
$74.11 /

+0.04 (+0.05%)

CVS CVS Health
$74.11 /

+0.04 (+0.05%)

CVS CVS Health
$74.11 /

+0.04 (+0.05%)

Earnings
City Holding reports Q4 EPS $1.40, consensus $1.08 » 07:35
01/25/21
01/25
07:35
01/25/21
07:35
CHCO

City Holding

$71.53 /

+0.68 (+0.96%)

The Company's net…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHCO City Holding
$71.53 /

+0.68 (+0.96%)

CHCO City Holding
$71.53 /

+0.68 (+0.96%)

09/24/20 Boenning & Scattergood
City Holding resumed with a Neutral at Boenning & Scattergood
07/09/20 Piper Sandler
City Holding resumed with a Neutral at Piper Sandler
CHCO City Holding
$71.53 /

+0.68 (+0.96%)

Hot Stocks
Kimberly-Clark sees FY21 Share repurchases of $650M-$750M  07:35
01/25/21
01/25
07:35
01/25/21
07:35
KMB

Kimberly-Clark

$132.24 /

+1.14 (+0.87%)

 
ShowHide Related Items >><<
KMB Kimberly-Clark
$132.24 /

+1.14 (+0.87%)

KMB Kimberly-Clark
$132.24 /

+1.14 (+0.87%)

01/21/21 Deutsche Bank
Kimberly-Clark price target lowered to $144 from $150 at Deutsche Bank
01/19/21 Bernstein
Kimberly-Clark initiated with a Market Perform at Bernstein
12/07/20 Wells Fargo
Kimberly-Clark initiated with an Underweight at Wells Fargo
10/16/20
Fly Intel: Top five analyst initiations
KMB Kimberly-Clark
$132.24 /

+1.14 (+0.87%)

KMB Kimberly-Clark
$132.24 /

+1.14 (+0.87%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.